Advertisement

Document › Details
908 Devices, Inc.. (12/6/17). "Press Release: 908 Devices Awarded 10-Year Contract Through U.S. Department of Defense CBRN Program".
![]() |
Organisation | 908 Devices Inc. (Nasdaq: MASS) |
Group | 908 Devices (Group) | |
Organisation 2 | Department of Defense (DOD) (US) | |
Group | United States (govt) | |
![]() |
Product | M908™ handheld mass spectrometer |
Product 2 | high-pressure mass spectrometry (HPMS™ technology) | |
![]() |
Person | Knopp, Kevin J. (908 Devices 201303 CEO + Co-founder before Thermo Fisher + Ahura Scientific) |
Person 2 | Kenneweg, John (908 Devices 201503 VP Sales) | |
908 Devices, a pioneer of analytical devices for chemical and biomolecule analysis, today announced it has been awarded a 10-year fielded contract through the United States Department of Defense’s (DOD) Joint Enterprise-Research, Development, Acquisition, and Production/Procurement (JE-RDAP) omnibus Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle. 908 Devices is recognized for its patented and award-winning high-pressure mass spectrometry™ (HPMS) technology, which powers its line of handheld chemical detection and identification devices. This includes the flagship M908™ and the MX908™, which launched in June of this year.
As a recipient of the $8.2 billion, multi-vendor contract, 908 Devices has been named a qualified contractor by the Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD), whose mission it is to protect the Joint Force from weapons of mass destruction by generating affordable capabilities. Leveraging the power of HPMS, 908 Devices will now have the opportunity to compete for JE-RDAP task orders specific to future research, development, production, and fielding of CBRN defense systems.
“We are excited to be named a qualified contractor and for the opportunities it provides.,” said Dr. Kevin J. Knopp, President and CEO, 908 Devices. “We believe our handheld high-pressure mass spec platform can play a critical role in the modern response mission and look forward to working closely with the military to support and enhance its CBRN response needs.”
“This has been an exciting year for our safety and security team, and being a recipient of the JE-RDAP contract allows us to be an innovation partner with the government,” said John Kenneweg, Vice President, 908 Devices. “We will continue to explore and push the boundaries of our HPMS technology so as to be ready to support the evolving CBRN mission for years to come. “
Record changed: 2023-06-05 |
Advertisement

More documents for 908 Devices (Group)
- [1] 908 Devices, Inc.. (8/9/22). "Press Release: 908 Devices Acquires Trace Analytics, Enabling On-line Bioanalytics". Boston, MA....
- [2] 908 Devices, Inc.. (3/7/22). "Press Release: 908 Devices Reports Fourth Quarter and Full Year 2021 Financial Results and Provides 2022 Revenue Outlook". Boston, MA....
- [3] 908 Devices, Inc.. (3/2/22). "Press Release: 908 Devices Appoints Tony J. Hunt, President and CEO, Repligen, to Its Board of Directors"....
- [4] 908 Devices, Inc.. (1/7/22). "Press Release: 908 Devices Announces GSK Purchases Fifth Rebel Cell Culture Media Analyzer". Boston, MA....
- [5] 908 Devices, Inc.. (6/22/21). "Press Release: 908 Devices Announces New Data Integrations with Key Industry Partners to Accelerate BioProcess Data Insights". Boston, MA....
- [6] 908 Devices, Inc.. (12/18/20). "Press Release: 908 Devices Announces Pricing of Initial Public Offering"....
- [7] 908 Devices, Inc.. (8/12/19). "Press Release: 908 Devices Launches the Rebel, the First At-line Spent Cell Media Analyzer for Bioprocess Labs". Boston, MA....
- [8] 908 Devices, Inc.. (7/25/19). "Press Release: 908 Devices Poised to Modernize Upstream Bioprocess Analytics with a Grant from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)". Boston, MA....
- [9] 908 Devices, Inc.. (6/14/19). "Press Release: 908 Devices Addresses Emerging Novichok Nerve Agent Threat, Expands Capabilities for MX908 Chemical Detection Device". Boston, MA....
- [10] 908 Devices, Inc.. (6/3/19). "Press Release: 908 Devices Broadens the ZipChip Platform, Brings New Capability to Biotherapeutics Researchers". Boston, MA....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement

» top